Toward a structome of Acinetobacter baumannii drug targets
© 2020 The Protein Society..
Acinetobacter baumannii is well known for causing hospital-associated infections due in part to its intrinsic antibiotic resistance as well as its ability to remain viable on surfaces and resist cleaning agents. In a previous publication, A. baumannii strain AB5075 was studied by transposon mutagenesis and 438 essential gene candidates for growth on rich-medium were identified. The Seattle Structural Genomics Center for Infectious Disease entered 342 of these candidate essential genes into our pipeline for structure determination, in which 306 were successfully cloned into expression vectors, 192 were detectably expressed, 165 screened as soluble, 121 were purified, 52 crystalized, 30 provided diffraction data, and 29 structures were deposited in the Protein Data Bank. Here, we report these structures, compare them with human orthologs where applicable, and discuss their potential as drug targets for antibiotic development against A. baumannii.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Protein science : a publication of the Protein Society - 29(2020), 3 vom: 06. März, Seite 789-802 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tillery, Logan M [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 02.02.2021 Date Revised 03.03.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/pro.3826 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305292358 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305292358 | ||
| 003 | DE-627 | ||
| 005 | 20231225120846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/pro.3826 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1017.xml |
| 035 | |a (DE-627)NLM305292358 | ||
| 035 | |a (NLM)31930600 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tillery, Logan M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Toward a structome of Acinetobacter baumannii drug targets |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.02.2021 | ||
| 500 | |a Date Revised 03.03.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 The Protein Society. | ||
| 520 | |a Acinetobacter baumannii is well known for causing hospital-associated infections due in part to its intrinsic antibiotic resistance as well as its ability to remain viable on surfaces and resist cleaning agents. In a previous publication, A. baumannii strain AB5075 was studied by transposon mutagenesis and 438 essential gene candidates for growth on rich-medium were identified. The Seattle Structural Genomics Center for Infectious Disease entered 342 of these candidate essential genes into our pipeline for structure determination, in which 306 were successfully cloned into expression vectors, 192 were detectably expressed, 165 screened as soluble, 121 were purified, 52 crystalized, 30 provided diffraction data, and 29 structures were deposited in the Protein Data Bank. Here, we report these structures, compare them with human orthologs where applicable, and discuss their potential as drug targets for antibiotic development against A. baumannii | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a X-ray structure | |
| 650 | 4 | |a antibiotic resistance | |
| 650 | 4 | |a antibiotic targets | |
| 650 | 4 | |a gram-negative | |
| 650 | 4 | |a structure based drug design | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Bacterial Proteins |2 NLM | |
| 650 | 7 | |a Coproporphyrinogen Oxidase |2 NLM | |
| 650 | 7 | |a EC 1.3.3.3 |2 NLM | |
| 650 | 7 | |a Uroporphyrinogen Decarboxylase |2 NLM | |
| 650 | 7 | |a EC 4.1.1.37 |2 NLM | |
| 650 | 7 | |a Methionine-tRNA Ligase |2 NLM | |
| 650 | 7 | |a EC 6.1.1.10 |2 NLM | |
| 700 | 1 | |a Barrett, Kayleigh F |e verfasserin |4 aut | |
| 700 | 1 | |a Dranow, David M |e verfasserin |4 aut | |
| 700 | 1 | |a Craig, Justin |e verfasserin |4 aut | |
| 700 | 1 | |a Shek, Roger |e verfasserin |4 aut | |
| 700 | 1 | |a Chun, Ian |e verfasserin |4 aut | |
| 700 | 1 | |a Barrett, Lynn K |e verfasserin |4 aut | |
| 700 | 1 | |a Phan, Isabelle Q |e verfasserin |4 aut | |
| 700 | 1 | |a Subramanian, Sandhya |e verfasserin |4 aut | |
| 700 | 1 | |a Abendroth, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Lorimer, Donald D |e verfasserin |4 aut | |
| 700 | 1 | |a Edwards, Thomas E |e verfasserin |4 aut | |
| 700 | 1 | |a Van Voorhis, Wesley C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Protein science : a publication of the Protein Society |d 1993 |g 29(2020), 3 vom: 06. März, Seite 789-802 |w (DE-627)NLM012652415 |x 1469-896X |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2020 |g number:3 |g day:06 |g month:03 |g pages:789-802 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/pro.3826 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2020 |e 3 |b 06 |c 03 |h 789-802 | ||